For research teamsHelp me find a study
Back to all studies
CompletedNCT00528905

AZD3480 for schizophrenia

This study is completed in the United States and in Canada. It is testing AZD3480 for schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether Cognitive Improvement may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive Cognitive Improvement, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in Canada and in the United States.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateAugust 2007
Recruitment status
Completed
Enrollment listed in the registry
400
Sponsor
AstraZeneca
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States, Canada
Age range
From 18 Years to 55 Years
Official registry ID
NCT00528905
Official title
A Multi-Center Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase IIb Proof of Concept Study With 3 Oral Groups of AZD3480 During 12 Weeks Treatment of Cognitive Deficits in Patients With Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT00528905. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

Canada · 14 sites
  • Research Site
    Calgary, Alberta
    Site status: Not listed — confirm with the team
  • Research Site
    Red Deer, Alberta
    Site status: Not listed — confirm with the team
  • Research Site
    Penticton, British Columbia
    Site status: Not listed — confirm with the team
  • Research Site
    Victoria, British Columbia
    Site status: Not listed — confirm with the team
  • Research Site
    Winnipeg, Manitoba
    Site status: Not listed — confirm with the team
  • Research Site
    Halifax, Nova Scotia
    Site status: Not listed — confirm with the team
  • Research Site
    Sydney, Nova Scotia
    Site status: Not listed — confirm with the team
  • Research Site
    Burlington, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Greater Sudbury, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Mississauga, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Orléans, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Toronto, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Windsor, Ontario
    Site status: Not listed — confirm with the team
  • Research Site
    Montreal, Quebec
    Site status: Not listed — confirm with the team
United States · 66 sites
  • Research Site
    Little Rock, Arkansas
    Site status: Not listed — confirm with the team
  • Research Site
    Anaheim, California
    Site status: Not listed — confirm with the team
  • Research Site
    Cerritos, California
    Site status: Not listed — confirm with the team
  • Research Site
    Costa Mesa, California
    Site status: Not listed — confirm with the team
  • Research Site
    Escondido, California
    Site status: Not listed — confirm with the team
  • Research Site
    Garden Grove, California
    Site status: Not listed — confirm with the team
  • Research Site
    Long Beach, California
    Site status: Not listed — confirm with the team
  • Research Site
    Los Angeles, California
    Site status: Not listed — confirm with the team
  • Research Site
    Oceanside, California
    Site status: Not listed — confirm with the team
  • Research Site
    Pasadena, California
    Site status: Not listed — confirm with the team
  • Research Site
    Pico Rivera, California
    Site status: Not listed — confirm with the team
  • Research Site
    San Diego, California
    Site status: Not listed — confirm with the team
  • Research Site
    Santa Ana, California
    Site status: Not listed — confirm with the team
  • Research Site
    New Britain, Connecticut
    Site status: Not listed — confirm with the team
  • Research Site
    New Haven, Connecticut
    Site status: Not listed — confirm with the team
  • Research Site
    Washington D.C., District of Columbia
    Site status: Not listed — confirm with the team
  • Research Site
    Boca Raton, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Coral Gables, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    North Miami, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Orlando, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Tampa, Florida
    Site status: Not listed — confirm with the team
  • Research Site
    Atlanta, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Augusta, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Marietta, Georgia
    Site status: Not listed — confirm with the team
  • Research Site
    Chicago, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    Joliet, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    Schaumburg, Illinois
    Site status: Not listed — confirm with the team
  • Research Site
    Indianapolis, Indiana
    Site status: Not listed — confirm with the team
  • Research Site
    New Orleans, Louisiana
    Site status: Not listed — confirm with the team
  • Research Site
    Glen Burnie, Maryland
    Site status: Not listed — confirm with the team
  • Research Site
    Haverhill, Massachusetts
    Site status: Not listed — confirm with the team
  • Research Site
    Pittsfield, Massachusetts
    Site status: Not listed — confirm with the team
  • Research Site
    Minneapolis, Minnesota
    Site status: Not listed — confirm with the team
  • Research Site
    St Louis, Missouri
    Site status: Not listed — confirm with the team
  • Research Site
    Las Vegas, Nevada
    Site status: Not listed — confirm with the team
  • Research Site
    Nashua, New Hampshire
    Site status: Not listed — confirm with the team
  • Research Site
    Cherry Hill, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    Clementon, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    East Orange, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    Newark, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    Paramus, New Jersey
    Site status: Not listed — confirm with the team
  • Research Site
    Brooklyn, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Cedarhurst, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Elmsford, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Glen Oaks, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Jamaica, New York
    Site status: Not listed — confirm with the team
  • Research Site
    New York, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Rochester, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Staten Island, New York
    Site status: Not listed — confirm with the team
  • Research Site
    Cincinnati, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Columbus, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Kettering, Ohio
    Site status: Not listed — confirm with the team
  • Research Site
    Oklahoma City, Oklahoma
    Site status: Not listed — confirm with the team
  • Research Site
    Allentown, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Site
    DuBois, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Site
    Norristown, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Site
    Philadelphia, Pennsylvania
    Site status: Not listed — confirm with the team
  • Research Site
    Charleston, South Carolina
    Site status: Not listed — confirm with the team
  • Research Site
    Memphis, Tennessee
    Site status: Not listed — confirm with the team
  • Research Site
    Austin, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    DeSoto, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Houston, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Irving, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    San Antonio, Texas
    Site status: Not listed — confirm with the team
  • Research Site
    Richmond, Virginia
    Site status: Not listed — confirm with the team
  • Research Site
    Spokane, Washington
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving AZD3480. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 55 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by AstraZeneca, which appears to be unknown or unclear. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.